The Motley Fool Discussion Boards
CAPS / CAPS Addictions 12-Step Program
|Subject: FDA approval!||Date: 4/7/2008 3:35 PM|
|Author: HelicalZz||Number: 115 of 124|
I couldn't help but notice that Regeneron recently received FDA approval of Arcalyst (rilonacept) for CAPS. Good to see there are people working on this.
Note: Cryopyrin-Associated Periodic Syndromes (CAPS), a group of rare, inherited, auto-inflammatory conditions characterized by life-long symptoms of rash, fever/chills, joint pain, eye redness/pain, and fatigue; and Motley Fool CAPS are not necessarily indications that should be treated similarly.
Nevertheless, here is a quote from the press release.
"Recognizing the painful, isolated lives experienced by patients with CAPS, we are pleased that we can offer these patients an FDA-approved therapy that helps control its debilitating symptoms," said Leonard S. Schleifer, M.D., Ph.D., Regeneron's president and chief executive officer.
Zz - just saying
|Copyright 1996-2016 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us|